Market

Saw participation from 450 delegates and more than 50 members from the pharma industry

Attended by national and international nutrition experts, it focussed on nutritional requirements for all the age groups and…

The additional grant of $3.4 million will enable development of new drugs to combat tuberculosis

Will help in PET imaging of beta-amyloid neuritic plaques in the brain

Strict regulation of first-line TB drug formulations and prescription practices in the private sector is needed in India

Xolair is the first and only licensed therapy in the US for the nearly 50 per cent of patients with CIU

Glenmark Pharmaceuticals has informed the Bombay Stock Exchange that the company through its Swiss subsidiary has received $4…

Falk Pharma will initially concentrate on development in primary biliary cirrhosis (PBC)

Clocks Rs 5902 crores in the same month

Around 20,000 pharma trade professional/decision makers are likely to attend the event